{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:06:33Z","timestamp":1759190793994,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03553-5","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:08:09Z","timestamp":1759136889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMPD2 affects the prognosis of cancer patients by mediating lipid metabolism and the immune microenvironment"],"prefix":"10.1007","volume":"16","author":[{"given":"Qing-Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Long","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"3553_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. Cancer JC. 2024;74(1):12\u201349. doi: 10.3322\/caac.21820. Epub 2024 Jan 17. Erratum in: CA Cancer J Clin. 2024 Mar-Apr;74(2):203. doi: 10.3322\/caac.21830.","DOI":"10.3322\/caac.21820"},{"key":"3553_CR2","doi-asserted-by":"publisher","unstructured":"Clarke CJ. Neutral sphingomyelinases in cancer. In Advances in cancer research, Vol. 140. Elsevier; 2018. pp. 97\u2013119https:\/\/doi.org\/10.1016\/bs.acr.2018.04.010.","DOI":"10.1016\/bs.acr.2018.04.010"},{"issue":"7","key":"3553_CR3","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1111\/cas.14453","volume":"111","author":"B Liu","year":"2020","unstructured":"Liu B, Xiao J, Dong M, Qiu Z, Jin J. Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid-like 3B. Cancer Sci. 2020;111(7):2259\u201374. https:\/\/doi.org\/10.1111\/cas.14453.","journal-title":"Cancer Sci"},{"key":"3553_CR4","doi-asserted-by":"publisher","unstructured":"Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4(8):604\u201316. https:\/\/doi.org\/10.1038\/nrc1411.","DOI":"10.1038\/nrc1411"},{"issue":"24","key":"3553_CR5","doi-asserted-by":"publisher","first-page":"21565","DOI":"10.1074\/jbc.M110.193375","volume":"286","author":"CJ Clarke","year":"2011","unstructured":"Clarke CJ, Mediwala K, Jenkins RW, Sutton CA, Tholanikunnel BG, Hannun YA. Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase. J Biol Chem. 2011;286(24):21565\u201376. https:\/\/doi.org\/10.1074\/jbc.M110.193375.","journal-title":"J Biol Chem"},{"issue":"20","key":"3553_CR6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1182\/blood.2023022147","volume":"142","author":"SN Hurwitz","year":"2023","unstructured":"Hurwitz SN, Jung SK, Kobulsky DR, Fazelinia H, Spruce LA, P\u00e9rez EB, Groen N, Mesaros C, Kurre P. Neutral Sphingomyelinase Blockade enhances hematopoietic stem cell fitness through an integrated stress response. Blood. 2023;142(20):1708\u201323. https:\/\/doi.org\/10.1182\/blood.2023022147.","journal-title":"Blood"},{"key":"3553_CR7","doi-asserted-by":"publisher","unstructured":"Sindhu S, Leung YH, Arefanian H, Madiraju SRM, Al-Mulla F, Ahmad R, Prentki M. Neutral sphingomyelinase\u20102 and cardiometabolic diseases. Obes Rev. 2021;22(8). https:\/\/doi.org\/10.1111\/obr.13248.","DOI":"10.1111\/obr.13248"},{"issue":"2","key":"3553_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/cdd.2014.128","volume":"22","author":"T Yabu","year":"2015","unstructured":"Yabu T, Shiba H, Shibasaki Y, Nakanishi T, Imamura S, Touhata K, Yamashita M. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling. Cell Death Differ. 2015;22(2):258\u201373. https:\/\/doi.org\/10.1038\/cdd.2014.128.","journal-title":"Cell Death Differ"},{"key":"3553_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","volume":"57","author":"AA Shamseddine","year":"2015","unstructured":"Shamseddine AA, Airola MV, Hannun YA. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes. Adv Biol Regul. 2015;57:24\u201341. https:\/\/doi.org\/10.1016\/j.jbior.2014.10.002.","journal-title":"Adv Biol Regul"},{"issue":"10","key":"3553_CR10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1084\/jem.189.10.1581","volume":"189","author":"L Tonnetti","year":"1999","unstructured":"Tonnetti L, Ver\u00ed MC, Bonvini E, D\u2019Adamio L. A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction. J Exp Med. 1999;189(10):1581\u20139. https:\/\/doi.org\/10.1084\/jem.189.10.1581.","journal-title":"J Exp Med"},{"issue":"20","key":"3553_CR11","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1111\/febs.14635","volume":"285","author":"M Lin","year":"2018","unstructured":"Lin M, Liao W, Dong M, Zhu R, Xiao J, Sun T, Chen Z, Wu B, Jin J. Exosomal neutral Sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin\/ceramide. FEBS J. 2018;285(20):3835\u201348. https:\/\/doi.org\/10.1111\/febs.14635.","journal-title":"FEBS J"},{"issue":"5","key":"3553_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1194\/jlr.M080879","volume":"59","author":"L Zhong","year":"2018","unstructured":"Zhong L, Kong JN, Dinkins MB, Leanhart S, Zhu Z, Spassieva SD, Qin H, Lin HP, Elsherbini A, Wang R, Jiang X, Nikolova-Karakashian M, Wang G, Bieberich E. Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice. J Lipid Res. 2018;59(5):795\u2013804.","journal-title":"J Lipid Res"},{"key":"3553_CR13","doi-asserted-by":"publisher","first-page":"745092","DOI":"10.3389\/fonc.2021.745092","volume":"11","author":"O Companioni","year":"2021","unstructured":"Companioni O, Mir C, Garcia-Mayea Y, LLeonart ME. Targeting sphingolipids for cancer therapy. Front Oncol. 2021;11:745092. https:\/\/doi.org\/10.3389\/fonc.2021.745092.","journal-title":"Front Oncol"},{"issue":"29","key":"3553_CR14","doi-asserted-by":"publisher","first-page":"eadg2697","DOI":"10.1126\/sciadv.adg2697","volume":"9","author":"S Han","year":"2023","unstructured":"Han S, Bao X, Zou Y, Wang L, Li Y, Yang L, Liao A, Zhang X, Jiang X, Liang D, Dai Y, Zheng QC, Yu Z, Guo J. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Sci Adv. 2023;9(29):eadg2697. https:\/\/doi.org\/10.1126\/sciadv.adg2697.","journal-title":"Sci Adv"},{"issue":"1","key":"3553_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, Liu Z, Yang L, Jiang Q, Cheng Q, Luo P, Liu G. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22(1):159. https:\/\/doi.org\/10.1186\/s12943-023-01860-5.","journal-title":"Mol Cancer"},{"issue":"8","key":"3553_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.trecan.2017.06.005","volume":"3","author":"H Wang","year":"2017","unstructured":"Wang H, Franco F, Ho PC. Metabolic regulation of Tregs in cancer: opportunities for immunotherapy. Trends Cancer. 2017;3(8):583\u201392. https:\/\/doi.org\/10.1016\/j.trecan.2017.06.005.","journal-title":"Trends Cancer"},{"issue":"2","key":"3553_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/imm.12036","volume":"138","author":"D Lindau","year":"2013","unstructured":"Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 2013;138(2):105\u201315. https:\/\/doi.org\/10.1111\/imm.12036.","journal-title":"Immunology"},{"issue":"12","key":"3553_CR18","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.3390\/ijms22126492","volume":"22","author":"P Giussani","year":"2021","unstructured":"Giussani P, Prinetti A, Tringali C. The role of sphingolipids in cancer immunotherapy. Int J Mol Sci. 2021;22(12):6492. https:\/\/doi.org\/10.3390\/ijms22126492.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3553_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrc1411","volume":"4","author":"B Ogretmen","year":"2004","unstructured":"Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4(8):604\u201316. https:\/\/doi.org\/10.1038\/nrc1411.","journal-title":"Nat Rev Cancer"},{"key":"3553_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","volume":"61","author":"A Gomez-Mu\u00f1oz","year":"2016","unstructured":"Gomez-Mu\u00f1oz A, Presa N, Gomez-Larrauri A, Rivera I-G, Trueba M, Ordo\u00f1ez M. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res. 2016;61:51\u201362. https:\/\/doi.org\/10.1016\/j.plipres.2015.09.002.","journal-title":"Prog Lipid Res"},{"issue":"2","key":"3553_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.canlet.2011.07.010","volume":"332","author":"B Henry","year":"2013","unstructured":"Henry B, M\u00f6ller C, Dimanche-Boitrel M-T, Gulbins E, Becker KA. Targeting the ceramide system in cancer. Cancer Lett. 2013;332(2):286\u201394. https:\/\/doi.org\/10.1016\/j.canlet.2011.07.010.","journal-title":"Cancer Lett"},{"key":"3553_CR22","doi-asserted-by":"publisher","unstructured":"Whitman SP, Civoli F, Daniel LW. Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation. J Biol Chem. 1997;272(38):23481-4. https:\/\/doi.org\/10.1074\/jbc.272.38.23481.","DOI":"10.1074\/jbc.272.38.23481"},{"key":"3553_CR23","doi-asserted-by":"publisher","unstructured":"Hendley AM, Ashe S, Urano A, Ng M, Phu TA, Peng XL, Luan C, Finger AM, Jang GH, Kerper NR, Berrios DI, Jin D, Lee J, Riahi IR, Gbenedio OM, Chung C, Roose JP, Yeh JJ, Gallinger S, Biankin AV, O\u2019Kane GM, Ntranos V, Chang DK, Dawson DW, Kim GE, Weaver VM, Raffai RL, Hebrok M. [preprint]SMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer. BioRxiv. 2024 Sep 25:2024.09.23.614610. https:\/\/doi.org\/10.1101\/2024.09.23.614610.","DOI":"10.1101\/2024.09.23.614610"},{"key":"3553_CR24","doi-asserted-by":"publisher","unstructured":"Montfort A, Bertrand F, Rochotte J, Gilhodes J, Filleron T, Milh\u00e8s J, Dufau C, Imbert C, Riond J, Tosolini M, Clarke CJ, Dufour F, Constantinescu AA, Junior NDF, Garcia V, Record M, Cordelier P, Brousset P, Rochaix P, et al. Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy. Cancer Immunol Res. 2021;9(5):568\u2013582. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0342.","DOI":"10.1158\/2326-6066.CIR-20-0342."},{"key":"3553_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbw063","author":"X Yang","year":"2016","unstructured":"Yang X, Gao L, Zhang S. Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. Brief Bioinform. 2016. https:\/\/doi.org\/10.1093\/bib\/bbw063.","journal-title":"Brief Bioinform"},{"issue":"1","key":"3553_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","volume":"21","author":"KC Ohaegbulam","year":"2015","unstructured":"Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med. 2015;21(1):24\u201333. https:\/\/doi.org\/10.1016\/j.molmed.2014.10.009.","journal-title":"Trends Mol Med"},{"key":"3553_CR27","doi-asserted-by":"publisher","unstructured":"Li R, Han D, Shi J, Han Y, Tan P, Zhang R, Li J. Choosing tumor mutational burden wisely for immunotherapy: a hard road to explore. Biochim Biophys Acta (BBA) Rev Cancer. 2020;1874(2):188420. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188420.","DOI":"10.1016\/j.bbcan.2020.188420"},{"key":"3553_CR28","doi-asserted-by":"publisher","first-page":"755284","DOI":"10.3389\/fcell.2021.755284","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Peng J, Du H, Zhang N, Fang X. Identification and validation of Immune- and Stemness-Related prognostic signature of melanoma. Front Cell Dev Biology. 2021;9:755284. https:\/\/doi.org\/10.3389\/fcell.2021.755284.","journal-title":"Front Cell Dev Biology"},{"key":"3553_CR29","doi-asserted-by":"publisher","unstructured":"Jin HR, Wang J, Wang ZJ et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16(1):103. https:\/\/doi.org\/10.1186\/s13045-023-01498-2","DOI":"10.1186\/s13045-023-01498-2"},{"key":"3553_CR30","doi-asserted-by":"publisher","first-page":"3028387","DOI":"10.1155\/2020\/3028387","volume":"2020","author":"AM Alzahrani","year":"2020","unstructured":"Alzahrani AM, Rajendran P. The multifarious link between cytochrome P450s and cancer. Oxid Med Cell Longev. 2020;2020:3028387. https:\/\/doi.org\/10.1155\/2020\/3028387. Published 2020 Jan 3.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"3553_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","volume":"15","author":"PP Lee","year":"2001","unstructured":"Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, P\u00e9rez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JH, Tucker SM, Weaver WM, Kelso A, Jaenisch R, Wilson CB. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 2001;15(5):763\u201374. https:\/\/doi.org\/10.1016\/S1074-7613(01)00227-8.","journal-title":"Immunity"},{"key":"3553_CR32","doi-asserted-by":"publisher","unstructured":"Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway Blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8(328). https:\/\/doi.org\/10.1126\/scitranslmed.aad7118.","DOI":"10.1126\/scitranslmed.aad7118"},{"key":"3553_CR33","doi-asserted-by":"publisher","unstructured":"Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, Miller ML, Rekhtman N, Moreira AL, Ibrahim F, Bruggeman C, Gasmi B, Zappasodi R, Maeda Y, Sander C, et al. Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer. Science. 2015;348(6230):124\u2013128. https:\/\/doi.org\/10.1126\/science.aaa1348.","DOI":"10.1126\/science.aaa1348."},{"key":"3553_CR34","doi-asserted-by":"publisher","unstructured":"Thorsson V, Gibbs DL, Brown SD et al. The immune landscape of cancer [published correction appears in Immunity. 2019;51(2):411\u2013412. https:\/\/doi.org\/10.1016\/j.immuni.201908.004]. Immunity. 2018;48(4):812\u2013830.e14. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023.","DOI":"10.1016\/j.immuni.201908.004]."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03553-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:08:11Z","timestamp":1759136891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03553-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03553-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Nanfang Hospital, Southern Medical University (No. NEFC-2021-394).All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1741"}}